GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmesis International Ltd (SGX:BFK) » Definitions » Market Cap

Pharmesis International (SGX:BFK) Market Cap : S$15.85 Mil (As of Mar. 31, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Pharmesis International Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pharmesis International's share price for the quarter that ended in Dec. 2024 was S$0.575. Pharmesis International's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 31.70 Mil. Therefore, Pharmesis International's market cap for the quarter that ended in Dec. 2024 was S$18.23 Mil.

Pharmesis International's quarterly market cap declined from Dec. 2023 (S$2.70 Mil) to Jun. 2024 (S$2.57 Mil) but then increased from Jun. 2024 (S$2.57 Mil) to Dec. 2024 (S$18.23 Mil).

Pharmesis International's annual market cap increased from Dec. 2022 (S$2.51 Mil) to Dec. 2023 (S$2.70 Mil) and increased from Dec. 2023 (S$2.70 Mil) to Dec. 2024 (S$18.23 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pharmesis International's Enterprise Value for Today is S$17.94 Mil.


Pharmesis International Market Cap Historical Data

The historical data trend for Pharmesis International's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmesis International Market Cap Chart

Pharmesis International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.56 3.45 2.51 2.70 18.23

Pharmesis International Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.51 4.00 2.70 2.57 18.23

Competitive Comparison of Pharmesis International's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmesis International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmesis International's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmesis International's Market Cap distribution charts can be found below:

* The bar in red indicates where Pharmesis International's Market Cap falls into.


;
;

Pharmesis International Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Pharmesis International's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=S$0.575*31.700
=S$18.23

Pharmesis International's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=S$0.575*31.700
=S$18.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmesis International  (SGX:BFK) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Pharmesis International Market Cap Related Terms

Thank you for viewing the detailed overview of Pharmesis International's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmesis International Business Description

Traded in Other Exchanges
N/A
Address
5 Kallang Sector, No. 03-02, Singapore, SGP, 349279
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution. The company derives revenue from the sale of medicines to domestic customers in China.